M. Rovaris et al., Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis, AM J NEUROR, 21(2), 2000, pp. 402-408
Citations number
44
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Neurosciences & Behavoir
BACKGROUND AND PURPOSE: We assessed whether the extent of macro- and micros
copic disease in the cortical and subcortical brain tissue, as revealed by
MR and magnetization transfer (MT) imaging, correlates with cognitive dysfu
nction in patients with multiple sclerosis (MS),
METHODS: Dual-echo rapid acquisition with relaxation enhancement (RARE), fa
st fluid-attenuated inversion recovery (fast-FLAIR), T1-weighted, and MT MR
images of the brain were obtained from 16 MS patients with cognitive impai
rment and from six without. Impaired and unimpaired patients were similar a
cross demographic and other disease-related variables, Total and cortical/s
ubcortical lesion loads were assessed using RARE, fast-FLAIR, and T1-weight
ed sequences. In each patient, cortical/subcortical disease was also assess
ed by means of MT ratio (MTR) histographic analysis.
RESULTS: All the impaired patients had multiple hyperintense lesions in the
cortical/subcortical regions on both RARE and fast-FLAIR images; two unimp
aired patients had such lesions on the RARE images and four had them on the
fast-FLAIR images. Total and cortical/subcortical RARE/fast-FLAIR hyperint
ense and T1 hypointense lesion loads were significantly greater in the grou
p of cognitively impaired patients. Patients with cognitive deficits also h
ad significantly lower MTR histographic values for all the variables, A mul
tivariate regression model showed that average cortical/subcortical brain M
TR was the only factor that was significantly associated with cognitive imp
airment.
CONCLUSION: The extent and severity of MS disease in the cortical and subco
rtical regions significantly influence the cognitive functions of MS patien
ts. MTR histographic findings suggest that subtle changes undetectable by c
onventional imaging are also important in determining MS cognitive decline.